Enliven Therapeutics, Inc. (ELVN)
(Delayed Data from NSDQ)
$18.84 USD
-0.38 (-1.98%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $18.89 +0.05 (0.27%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ELVN 18.84 -0.38(-1.98%)
Will ELVN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELVN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELVN
Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect?
Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why
ELVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Momentum in Enliven Therapeutics, Inc. (ELVN) Should Keep going
Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High?
Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet
Other News for ELVN
BlackRock, Inc. Reduces Stake in Enliven Therapeutics Inc.
Enliven Therapeutics Inc Breaks Above 200-Day Moving Average - Bullish for ELVN
COMMODORE CAPITAL LP Acquires 1,175,000 Shares in Cidara Therapeutics Inc
Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday
Enliven Therapeutics (ELVN) Receives Raised Price Target from HC Wainwright & Co. ...